Alamar Biosciences, Inc. (California) (ALMR)
34.36
+1.90
(+5.85%)
USD |
NASDAQ |
Oct 02, 16:00
34.62
+0.26
(+0.76%)
After-Hours: 20:00
Alamar Biosciences Market Cap : 2.384B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.384B |
| October 01, 2026 | 2.252B |
| September 30, 2026 | 2.364B |
| September 29, 2026 | 2.266B |
| September 28, 2026 | 2.263B |
| September 25, 2026 | 2.276B |
| September 24, 2026 | 2.304B |
| September 23, 2026 | 2.230B |
| September 22, 2026 | 2.305B |
| September 21, 2026 | 2.432B |
| September 18, 2026 | 2.418B |
| September 17, 2026 | 2.221B |
| September 16, 2026 | 2.039B |
| September 15, 2026 | 1.995B |
| September 14, 2026 | 1.942B |
| September 11, 2026 | 1.935B |
| September 10, 2026 | 1.927B |
| September 09, 2026 | 2.009B |
| September 08, 2026 | 2.078B |
| September 04, 2026 | 2.137B |
| September 03, 2026 | 2.121B |
| September 02, 2026 | 2.116B |
| September 01, 2026 | 2.037B |
| August 31, 2026 | 2.119B |
| August 28, 2026 | 2.131B |
| Date | Value |
|---|---|
| August 27, 2026 | 2.290B |
| August 26, 2026 | 2.365B |
| August 25, 2026 | 2.291B |
| August 24, 2026 | 2.269B |
| August 21, 2026 | 2.376B |
| August 20, 2026 | 2.404B |
| August 19, 2026 | 2.466B |
| August 18, 2026 | 2.287B |
| August 17, 2026 | 2.229B |
| August 14, 2026 | 2.301B |
| August 13, 2026 | 2.284B |
| August 12, 2026 | 2.298B |
| August 11, 2026 | 2.538B |
| August 10, 2026 | 1.942B |
| August 07, 2026 | 1.973B |
| August 06, 2026 | 1.948B |
| August 05, 2026 | 1.965B |
| August 04, 2026 | 1.879B |
| August 03, 2026 | 1.876B |
| July 31, 2026 | 1.758B |
| July 30, 2026 | 1.738B |
| July 29, 2026 | 1.689B |
| July 28, 2026 | 1.713B |
| July 27, 2026 | 1.691B |
| July 24, 2026 | 1.794B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| 10X Genomics, Inc. | 12.18B |
| Personalis, Inc. | 1.732B |
| Adaptive Biotechnologies Corp. | 4.509B |
| Champions Oncology, Inc. | 68.76M |
| Medpace Holdings, Inc. | 16.69B |
Market Cap Related Metrics
| PS Ratio | 28.12 |
| Price to Book Value | 7.621 |
| Price | 34.36 |
| Earnings Yield | -2.07% |